Literature DB >> 7906449

Sphingosines: antimicrobial barriers of the skin.

D J Bibel1, R Aly, S Shah, H R Shinefield.   

Abstract

Among the factors that control the survival of microorganisms on human stratum corneum are skin lipids, including sphingosines. Because the antibacterial spectrum of sphinganine resembles that of cell wall antibiotics, electron microscopy of sphinganine-treated and untreated S. aureus was performed; the lipid induced multiple lesions of cell wall, membrane evaginations and loss of ribosomes. However, comparisons of minimal inhibitory concentration of sphinganine for coccal forms and L-forms of S. aureus, which lack cell walls, and of the respective dose-related reductions in colony-forming units demonstrated both the susceptibility of L-forms and their superior resistance. Therefore, cell wall lesions are sequelae of a probable membrane reaction. Candida albicans was susceptible to sphinganine, sphingosine, dimethylsphingosine, and to a lesser degree, stearylamine. Liquid assays of these lipids against Trichophyton mentagrophytes, T. tonsurans and Epidermatophyton floccosum established their high susceptibility to sphingosine and stearylamine. Sphinganine was the least effective, perhaps due to the presence of L isomers; T. tonsurans was the most sensitive. These four lipids were found to be fungistatic, preventing germination and retarding thalli. Antifungal efficacy was confirmed in vitro on stratum corneum.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7906449     DOI: 10.2340/0001555573407411

Source DB:  PubMed          Journal:  Acta Derm Venereol        ISSN: 0001-5555            Impact factor:   4.437


  23 in total

1.  Bactericidal activities of milk lipids.

Authors:  R C Sprong; M F Hulstein; R Van der Meer
Journal:  Antimicrob Agents Chemother       Date:  2001-04       Impact factor: 5.191

Review 2.  The roles of cutaneous lipids in host defense.

Authors:  Carol L Fischer; Derek R Blanchette; Kim A Brogden; Deborah V Dawson; David R Drake; Jennifer R Hill; Philip W Wertz
Journal:  Biochim Biophys Acta       Date:  2013-08-29

Review 3.  The emerging role of peptides and lipids as antimicrobial epidermal barriers and modulators of local inflammation.

Authors:  N K Brogden; L Mehalick; C L Fischer; P W Wertz; K A Brogden
Journal:  Skin Pharmacol Physiol       Date:  2012-04-26       Impact factor: 3.479

4.  Protein Analysis of Sapienic Acid-Treated Porphyromonas gingivalis Suggests Differential Regulation of Multiple Metabolic Pathways.

Authors:  Carol L Fischer; Deborah V Dawson; Derek R Blanchette; David R Drake; Philip W Wertz; Kim A Brogden
Journal:  J Bacteriol       Date:  2015-10-19       Impact factor: 3.490

5.  Genetic Predictors of Susceptibility to Dermatophytoses.

Authors:  Susan M Abdel-Rahman
Journal:  Mycopathologia       Date:  2016-08-08       Impact factor: 2.574

6.  Genetic predictors of susceptibility to cutaneous fungal infections: a pilot genome wide association study to refine a candidate gene search.

Authors:  Susan M Abdel-Rahman; Barry L Preuett
Journal:  J Dermatol Sci       Date:  2012-05-27       Impact factor: 4.563

Review 7.  Immunology of diseases associated with Malassezia species.

Authors:  H Ruth Ashbee; E Glyn V Evans
Journal:  Clin Microbiol Rev       Date:  2002-01       Impact factor: 26.132

8.  Antibacterial activity of sphingoid bases and fatty acids against Gram-positive and Gram-negative bacteria.

Authors:  Carol L Fischer; David R Drake; Deborah V Dawson; Derek R Blanchette; Kim A Brogden; Philip W Wertz
Journal:  Antimicrob Agents Chemother       Date:  2011-12-12       Impact factor: 5.191

Review 9.  Cutaneous defenses against dermatophytes and yeasts.

Authors:  D K Wagner; P G Sohnle
Journal:  Clin Microbiol Rev       Date:  1995-07       Impact factor: 26.132

10.  Sphingoid bases are taken up by Escherichia coli and Staphylococcus aureus and induce ultrastructural damage.

Authors:  C L Fischer; K S Walters; D R Drake; D R Blanchette; D V Dawson; K A Brogden; P W Wertz
Journal:  Skin Pharmacol Physiol       Date:  2012-10-30       Impact factor: 3.479

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.